Articles dans des revues avec comité de lecture (45)
  1. 37. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Pieters, K., Anthoine, G., Mineur, P., Bron, D., & Lagneaux, L. (2010). A molecular score by quantitative PCR as a new prognostic tool at diagnosis for chronic lymphocytic leukemia patients. PloS one, 5(9). doi:10.1371/journal.pone.0012780
  2. 38. Stamatopoulos, B., Meuleman, N., De Bruyn, C., Mineur, P., Martiat, P., Bron, D., & Lagneaux, L. (2009). Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis. Leukemia, 23(12), 2281-2289. doi:10.1038/leu.2009.176
  3. 39. Stamatopoulos, B., Haibe-Kains, B., Equeter, C., Meuleman, N., Soree, A., De Bruyn, C., Hanosset, D., Bron, D., Martiat, P., & Lagneaux, L. (2009). Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA. Haematologica, 94(6), 790-799. doi:10.3324/haematol.2008.002626
  4. 40. Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Saussoy, P., Van Den Neste, E., Michaux, L., Heimann, P., Martiat, P., Bron, D., & Lagneaux, L. (2009). microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood, 113(21), 5237-5245. doi:10.1182/blood-2008-11-189407
  5. 41. Tondreau, T., Meuleman, N., Stamatopoulos, B., De Bruyn, C., Delforge, A., Dejeneffe, M., Martiat, P., Bron, D., & Lagneaux, L. (2009). In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues. Cytotherapy, 11(5), 559-569. doi:10.1080/14653240903051541
  6. 42. Meuleman, N., Stamatopoulos, B., Dejeneffe, M., El Housni, H., Lagneaux, L., & Bron, D. (2008). Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia, 22(10), 1882-1890. doi:10.1038/leu.2008.190
  7. 43. Tondreau, T., Dejeneffe, M., Meuleman, N., Stamatopoulos, B., Delforge, A., Martiat, P., Bron, D., & Lagneaux, L. (2008). Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells. BMC genomics, 9, 166. doi:10.1186/1471-2164-9-166
  8. 44. Lagneaux, L., Gillet, N., Stamatopoulos, B., Delforge, A., Dejeneffe, M., Massy, M., Meuleman, N., Kentos, A., Martiat, P., Willems, L., & Bron, D. (2007). Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Experimental hematology, 35(10), 1527-1537. doi:10.1016/j.exphem.2007.06.014
  9. 45. Stamatopoulos, B., Meuleman, N., Haibe-Kains, B., Duvillier, H., Massy, M., Martiat, P., Bron, D., & Lagneaux, L. (2007). Quantification of ZAP70 mRNA in B cells by real-time PCR is a powerful prognostic factor in chronic lymphocytic leukemia. Clinical chemistry, 53(10), 1757-1766. doi:10.1373/clinchem.2007.089326
    10.   Participations à des congrès et colloques internationaux (33)
  10. 1. Stamatopoulos, B., et al. (2025). Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into tumor-associated macrophages via an RNA-dependent mechanism. Paper session presented at 40th General Annual Meeting of the Belgian Hematology Society (February 2025: La Hulpe, Belgium).
  11. 2. Stamatopoulos, B. (2024). Extracellular vesicles from chronic lymphocytic leukemia cells promote leukemia aggressiveness by inducing the differentiation of monocytes into nurse-like cells via an RNA-dependent mechanism. Paper session presented at 7th French Society of Extracellular Vesicles (FSEV) annual meeting (November 2024: Strasbourg, France).
  12. 3. Stamatopoulos, B., et al. (2023). The light chain IgLV3-21 defines a new poor prognostic subgroup in Chronic Lymphocytic Leukemia: a multicenter study. Paper session presented at 18th Chronic Lymphocytic Leukemia Workshop (May 2023: Salzburg, Austria).
    13. << Précédent 1 2 3 4 5 6 7 8 Suivant >>